Attributes | Values |
---|
rdf:type
| |
http://linked.open...gbank/description
| - A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms. [PubChem] (en)
|
http://linked.open...gy/drugbank/group
| |
http://linked.open...ugbank/indication
| - For the treatment of severe, repeated, or long-lasting urinary tract infections, meningococcal meningitis, acute otitis media, trachoma, inclusion conjunctivitis, nocardiosis, chancroid, toxoplasmosis, malaria and other bacterial infections. (en)
|
http://linked.open...bank/manufacturer
| |
sameAs
| |
Title
| |
adms:identifier
| |
http://linked.open...mechanismOfAction
| - Sulfisoxazole is a competitive inhibitor of the enzyme dihydropteroate synthetase. It inhibits bacterial synthesis of dihydrofolic acid by preventing the condensation of the pteridine with para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid. (en)
|
http://linked.open...drugbank/packager
| |
http://linked.open...outeOfElimination
| - The mean urinary excretion recovery following oral administration of sulfisoxazole is 97% within 48 hours, of which 52% is intact drug, with the remaining as the N4-acetylated metabolite. It is excreted in human milk. (en)
|
http://linked.open.../drugbank/synonym
| - Sulfafurazole (en)
- Sulfadimethylisoxazole (en)
- Sulfafurazol (en)
- Sulfaisoxazole (en)
- Sulfasoxazole (en)
- Sulfisonazole (en)
- Sulfisoxasole (en)
- Sulfisoxazol (en)
- Sulfofurazole (en)
- Sulphafurazol (en)
- Sulphafurazole (en)
- Sulphaisoxazole (en)
- Sulphisoxazol (en)
- Sulphofurazole (en)
- 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide (en)
- 3,4-Dimethyl-5-sulfanilamidoisoxazole (en)
- 3,4-Dimethyl-5-sulfonamidoisoxazole (en)
- 3,4-Dimethyl-5-sulphanilamidoisoxazole (en)
- 3,4-Dimethyl-5-sulphonamidoisoxazole (en)
- 3,4-Dimethylisoxazole-5-sulfanilamide (en)
- 3,4-Dimethylisoxazole-5-sulphanilamide (en)
- 5-(4-Aminophenylsulfonamido)-3,4-dimethylisoxazole (en)
- 5-Sulfanilamido-3,4-dimethylisoxazole (en)
- 5-Sulphanilamido-3,4-dimethyl-isoxazole (en)
- 5-(P-Aminobenzenesulphonamido)-3,4-dimethylisoxazole (en)
- N'-(3,4)dimethylisoxazol-5-yl-sulphanilamide (en)
- N(1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide (en)
- N(1)-(3,4-Dimethyl-5-isoxazolyl)sulphanilamide (en)
- Sulfafurazolum (en)
- Sulphadimethylisoxazole (en)
- 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulphonamide (en)
- 5-(P-Aminobenzenesulfonamido)-3,4-dimethylisoxazole (en)
|
http://linked.open...drugbank/toxicity
| - LD<sub>50</sub>=6800 mg/kg (Orally in mice) (en)
|
http://linked.open.../drug/hasAHFSCode
| |
http://linked.open.../drugbank/mixture
| |
http://linked.open...ogy/drugbank/salt
| |
http://linked.open...y/mesh/hasConcept
| |
foaf:page
| |
http://linked.open...ugbank/IUPAC-Name
| |
http://linked.open...gy/drugbank/InChI
| |
http://linked.open...Molecular-Formula
| |
http://linked.open.../Molecular-Weight
| |
http://linked.open...noisotopic-Weight
| |
http://linked.open...y/drugbank/SMILES
| |
http://linked.open.../Water-Solubility
| |
http://linked.open...ogy/drugbank/logP
| |